Quanex Building Products CORP
For the period ended Jan 31, 2026. Filed Mar 6, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jan 31, 2026 · Filed Mar 6, 2026
NX$21.17-3.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statement of Stockholders’ Equity –
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
| Three Months Ended January 31, 2026 | CommonStock | AdditionalPaid-inCapital | RetainedEarnings | AccumulatedOtherComprehensive Loss | TreasuryStock | TotalStockholders’Equity |
|---|---|---|---|---|---|---|
| (In thousands, no per share amounts shown except in verbiage) | ||||||
| Balance at October 31, 2025 | $512 | $700,029 | $164,710 | $(35,439) | $(103,633) | $726,179 |
| Net loss | — | — | (4,071) | — | — | (4,071) |
| Foreign currency translation adjustment | — | — | — | 11,110 | — | 11,110 |
| Common dividends ($0.08 per share) | — | — | (3,676) | — | — | (3,676) |
| Stock-based compensation activity: | ||||||
| Expense related to stock-based compensation | — | 1,166 | — | — | — | 1,166 |
| Restricted stock awards granted | — | (5,415) | — | — | 5,415 | — |
| Other | — | (354) | — | — | — | (354) |
| Balance at January 31, 2026 | $512 | $695,426 | $156,963 | $(24,329) | $(98,218) | $730,354 |
| Three Months Ended January 31, 2025 | CommonStock | AdditionalPaid-inCapital | RetainedEarnings | AccumulatedOtherComprehensive Loss | TreasuryStock | TotalStockholders’Equity |
| (In thousands, no per share amounts shown except in verbiage) | ||||||
| Balance at October 31, 2024 | $513 | $701,008 | $430,405 | $(46,428) | $(74,752) | $1,010,746 |
| Net income | — | — | (14,885) | — | — | (14,885) |
| Foreign currency translation adjustment | — | — | — | (15,951) | — | (15,951) |
| Common dividends ($0.08 per share) | — | — | (3,812) | — | — | (3,812) |
| Treasury shares purchased, at cost | — | — | — | — | (3,698) | (3,698) |
| Stock-based compensation activity: | ||||||
| Expense related to stock-based compensation | — | 902 | — | — | — | 902 |
| Stock options exercised | — | 41 | — | — | 173 | 214 |
| Restricted stock awards granted | — | (1,894) | — | — | 1,894 | — |
| Performance restricted stock units vested | — | (1,300) | — | — | 1,300 | — |
| Other | (1) | (1,399) | — | — | — | (1,400) |
| Balance at January 31, 2025 | $512 | $697,358 | $411,708 | $(62,379) | $(75,083) | $972,116 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.